Mostrando 5 resultados de: 5
Filtros aplicados
Área temáticas
Enfermedades(5)
Farmacología y terapéutica(3)
Fisiología humana(3)
Medicina forense; incidencia de enfermedades(1)
Salud y seguridad personal(1)
Origen
scopus(5)
Ciprofibrate treatment decreases non-high density lipoprotein cholesterol and triglycerides and increases high density lipoprotein cholesterol in patients with frederickson type IV dyslipidemia phenotype
Conference ObjectAbstract: OBJECTIVE: The combination of hypertriglyceridemia and low high density lipoprotein (HDL) cholesteroPalabras claves:Ciprofibrate, Frederickson's type IV dyslipidemia, High density lipoprotein cholesterol, Hyperlipidemia, Low density lipoprotein cholesterol, Non-high density lipoprotein cholesterol, TriglyceridesAutores:Arráiz N., Bermúdez-Arias F., Cano-Peñaloza R., Cano-Ponce C., Contreras F., de Bravo M.C., De Diaz A.A., De Pirela N.L., Israili Z.H., Leal-Gonzalez E., Lemus-Antepaz M., Mengual-Moreno E., Puche-Medina G., Reyna-Villazmil N., Souki-Rincón A., Valasco M., Valmore BermúdezFuentes:scopusDetermination of Non-HDL cholesterol in diabetic and hypertensive patients
ArticleAbstract: Recently, it has been suggested that non-high-density lipoprotein (non-HDL) cholesterol measure is aPalabras claves:atherosclerosis, LDL, Non-HDL cholesterolAutores:Castro J., Contreras F., Dowling V., González M.C., Guerra-Torres X.E., Lares M., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusEffects of metoclopramide and metoclopramide/dopamine on blood pressure and insulin release in normotensive, hypertensive, and type 2 diabetic subjects
ArticleAbstract: The objective is to determine cardiovascular and insulin release effects under metoclopramide (MTC)Palabras claves:dopamine, Dopamine receptors, Hypertension, Insulin release, Metoclopramide, Type 2 DiabetesAutores:Bolívar H., Cano R.A., Contreras F., Fouillioux C., González M.C., Hernández-Hernandez R., Lares M., Valmore Bermúdez, Velasco M.Fuentes:scopusMetformin plus low-dose glimeperide significantly improves homeostasis model assessment for insulin resistance (HOMA<inf>IR</inf>) and β-cell function (HOMA<inf>β-cell</inf>) without hyperinsulinemia in patients with type 2 diabetes mellitus
Conference ObjectAbstract: OBJECTIVE: Type 2 diabetes mellitus is characterized by insulin resistance and defects in insulin sePalabras claves:Glimeperide, HOMA, Homeostasis model assessment, Insulin Resistance, Metformin, Type 2 Diabetes mellitus, β-cell functionAutores:Bermúdez-Arias F., Cano R.A., Cano-Ponce C., Ciscek A., Contreras F., Hernández-Hernandez R., Israili Z.H., Leal E.M., Lemus M.A., Medina M.T., Seyfi H.A., Souki-Rincón A., Valasco M., Valmore BermúdezFuentes:scopusTrimetazidine diminishes fasting glucose in rats with fasting hyperglycemia: a preliminary study.
ArticleAbstract: Trimetazidine is a drug with cardioprotective properties used in coronary artery disease. Its effectPalabras claves:Autores:Ambard M.J., Bermúdez F.A., Cano-Ponce C., Contreras F., Escalona D., Medina M.T., Souki-Rincón A., Valmore Bermúdez, Velasco M.Fuentes:scopus